Micafungin indications and usage

Jump to navigation Jump to search
Micafungin
Mycamine® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Indications and Usage

Mycamine® is indicated in adult and pediatric patients 4 months and older for:

  • Candidemia
  • Acute Disseminated Candidiasis
  • Candida Peritonitis and Abscesses
  • Esophageal Candidiasis

Mycamine has not been adequately studied in patients with endocarditis, osteomyelitis and meningitis due to Candida infections.

  • Prophylaxis of Candida Infections in Patients Undergoing Hematopoietic Stem Cell Transplantation

NOTE: The efficacy of Mycamine against infections caused by fungi other than Candida has not been established.[1]

References

  1. "MYCAMINE (MICAFUNGIN SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ASTELLAS PHARMA US, INC.]".

Adapted from the FDA Package Insert.